StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a report published on Monday morning. The brokerage issued a hold rating on the stock.
China Pharma Price Performance
CPHI opened at $0.14 on Monday. The stock has a 50-day moving average price of $0.22 and a 200-day moving average price of $0.22. The company has a current ratio of 0.79, a quick ratio of 0.26 and a debt-to-equity ratio of 0.22. China Pharma has a 12-month low of $0.12 and a 12-month high of $0.41.
Shares of China Pharma are scheduled to reverse split on the morning of Tuesday, April 15th. The 1-10 reverse split was announced on Friday, April 4th. The number of shares owned by shareholders will be adjusted after the market closes on Monday, April 14th.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
See Also
- Five stocks we like better than China Pharma
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Quantum Computing: The $6.5 Billion Opportunity You Can’t Ignore
- The 3 Best Retail Stocks to Shop for in August
- Are Tariffs Threatening Disney’s Comeback Story?
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Is Alphabet a Generational Buying Opportunity at These Levels?
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
